Skip to content

Combined Treatment of Umbilical Cord Mesenchymal Stem Cells and MEEK Micrografting on Severe Burn Patients

Combined Treatment of Umbilical Cord Mesenchymal Stem Cells and MEEK Micrografting on Severe Burn Patients in Wartime

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040932
Enrollment
Unknown
Registered
2020-12-16
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Interventions

External UCMSCs Group:External use of UCMSCs
Hypodermic UCMSCs Group:Hypodermic injection of UCMSCs

Sponsors

The 990th Hospital of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Subject inclusion criteria: (Subjects must meet all the requirements below before enrolled.) 1) Aged 18-60 years, male or female; 2) Total burn area > 30%TBSA; 3) The patient agrees to participate in this trial and signs the informed consent; 4) Blood level of AST, ALT, BUN, and Cr no more than twice the normal value; 5) Except the one infected with Hepatitis A, Hepatitis B, AIDS, tuberculosis or other infectious diseases in the active stage; 6) The burn sites of the subject include front and rear torso or limbs other than hands and feet.

Exclusion criteria

Exclusion criteria: Subject exclusion criteria: (Subjects meeting any of the requirements below shall not be enrolled.) 1) Severe wound infection; 2) Skin disease around the wound; 3) Diabetics; 4) Patients with cardiac pacemaker; 5) The researchers consider it inappropriate for patients with the disease to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Healing time;Scar score;Immunohistochemistry of scar tissue;

Secondary

MeasureTime frame
Pain score;

Countries

China

Contacts

Public ContactXiao Rong

The 990th Hospital of PLA

xr131@hotmail.com+86 18625316120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026